Skip to Main Content

Vaccines

The latest stories related to vaccines, including development and production issues.

Latest

Health Helen Branswell

Rwanda to receive experimental vaccines, therapeutics to combat Marburg outbreak

First Opinion Maria D. Van Kerkhove

WHO pandemic threat director: Here’s what needs to happen to combat mpox

Biotech Matthew Herper and Jason Mast

STAT Plus: Moderna touts research progress as it cuts R&D spending by $1.1 billion

First Opinion Robert Steinglass, Phillip Nieburg, and Ron Waldman

Gaza polio vaccination drive must include measles shots

Biotech Matthew Herper

STAT Plus: Vaxcyte shares boom as one of biotech’s big David vs. Goliath stories heats up

First Opinion Alan Levinovitz

STAT Plus: The alliance between RFK Jr. and Trump all comes down to their health-related worldview

Politics Isabella Cueto and Sarah Owermohle

STAT Plus: After decades of anti-vaccine rhetoric, RFK Jr. pivots to chronic diseases — and gets Trump on board

First Opinion Wilfredo R. Matias

To stop mpox from becoming the next pandemic, we must address global vaccine inequities

All Coverage

Health Associated Press

WHO launches plan to stanch mpox transmission and says the virus can be stopped

Health Helen Branswell

To counter mpox, vaccine maker could ramp up by another 8 million doses next year

advertisement

Morning Rounds Theresa Gaffney

Abortion, shingles, extreme heat, and sudden cardiac arrest

First Opinion Gregory A. Poland

Better safety studies could restore America’s confidence in vaccines

Letters to the editor Patrick Skerrett

Letters on Sonya Massey’s death, vaccine injuries, and much more

Special Report Andrew Joseph

4 takeaways from STAT’s story on the development of malaria vaccines

Special Report Andrew Joseph

Behind the malaria vaccines: A 40-year quest against one of humanity’s biggest killers

Health Helen Branswell

Bird flu snapshot: Upstart manufacturers in low- and middle-income countries to start early vaccine work

First Opinion Podcast Patrick Skerrett

Empathy should be the first response to people with vaccine injury, fears

Pharma Adam Feuerstein

STAT Plus: GSK buys mRNA-based Covid, flu vaccines from CureVac in restructured partnership

Health Helen Branswell

Moderna receives $176 million from BARDA for mRNA influenza vaccines

Health Helen Branswell

CDC advisory panel opts for a go-slow approach on expanding usage of RSV vaccines

Health Rohan Rajeev

On the road to eliminate rabies deaths, Gavi announces plan to improve human vaccination

The Readout Adam Feuerstein

STAT Plus: A biotech’s binary bet ends badly

The Readout Meghana Keshavan

STAT Plus: FDA offers new guidelines for Covid-19 vaccine

Letters to the editor Patrick Skerrett

Readers respond to a plea for rare disease progress, vaccine-related injury, and more

First Opinion Julie Sweetland

Telling new stories can help people see the value of vaccines

First Opinion Kizzmekia S. Corbett-Helaire

Empathy should guide responses to reported vaccine injuries

The Readout Meghana Keshavan

The biotech news you missed from the weekend

Health Helen Branswell

STAT Plus: FDA expands approval for GSK’s RSV vaccine to cover younger at-risk adults

The Readout Elaine Chen

Novavax will be able to supply Covid-19 vaccines this fall